Cite
Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients.
MLA
Kreijne, Joany E., et al. “Limited Added Value of Laboratory Monitoring in Thiopurine Maintenance Monotherapy in Inflammatory Bowel Disease Patients.” Alimentary Pharmacology & Therapeutics, vol. 51, no. 12, June 2020, pp. 1353–64. EBSCOhost, https://doi.org/10.1111/apt.15734.
APA
Kreijne, J. E., Vries, A. C., Veer, R. C., Bouma, G., Dijkstra, G., Voskuil, M. D., West, R., Moorsel, S. A. W., Jong, D. J., Boer, N. K., & Woude, C. J. (2020). Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics, 51(12), 1353–1364. https://doi.org/10.1111/apt.15734
Chicago
Kreijne, Joany E., Annemarie C. Vries, Rozanne C. Veer, Gerd Bouma, Gerard Dijkstra, Michiel D. Voskuil, Rachel West, et al. 2020. “Limited Added Value of Laboratory Monitoring in Thiopurine Maintenance Monotherapy in Inflammatory Bowel Disease Patients.” Alimentary Pharmacology & Therapeutics 51 (12): 1353–64. doi:10.1111/apt.15734.